M60.88 classifies non-infective, non-interstitial muscle inflammation (myositis) occurring at an anatomic site not represented by any other specific code in the M60.8x subcategory — a true residual 'other site' bucket.

Documentation tips

What should appear in the chart to support M60.88.

Source · Editorial brief grounded in 5 cited references ↓

• Name the specific muscle or anatomic region affected (e.g., 'psoas,' 'paraspinal,' 'pectoralis') — 'other site' requires a documented site that simply lacks its own M60.8x code.
• Record the type of myositis (inflammatory, drug-related, idiopathic) to confirm M60.88 is correct and not a more specific category such as infective (M60.08) or interstitial (M60.18).
• If imaging (MRI, ultrasound) or lab findings (elevated CK, aldolase) support the diagnosis, document them explicitly — these substantiate medical necessity for EMG/NCS and physical therapy services tied to this code.
• Document whether systemic inflammatory conditions (polymyositis, dermatomyositis, overlap syndrome) have been ruled out, since those carry distinct M33.xx codes that supersede M60.88.
• If more than one muscle group is involved, document each site; multiple sites shifts the correct code to M60.89.

Related CPT procedures

Procedure codes commonly billed with M60.88. Linking the right diagnosis to the right procedure is what establishes medical necessity.

Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis

Common coding pitfalls

The recurring mistakes coders make with M60.88 and adjacent codes.

Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓

• Assigning M60.88 when infective myositis is documented — infective cases belong in M60.08 (infective myositis, other site), a separate subcategory with distinct pathophysiology and coverage implications.
• Using M60.88 for polymyositis or dermatomyositis — those are systemic inflammatory myopathies coded to M33.0x–M33.2x, not to the M60.8x 'other myositis' block.
• Defaulting to M60.88 when the site is simply undocumented — unspecified site is M60.80 or M60.9; 'other site' requires an identified but unlisted location.
• Overlooking M60.89 (multiple sites) when the encounter note describes bilateral or multi-regional involvement — using M60.88 for a multi-site presentation is a specificity downgrade.
• Failing to apply a secondary cause code when myositis is drug-induced — the adverse effect or toxic reaction code should be sequenced first or alongside M60.88 per ICD-10-CM poisoning/adverse effect guidelines.

Clinical context

Source · Editorial summary grounded in 5 cited references ↓

Sibling codes

Other billable codes under M60.8 (laterality / anatomic variants).